Cargando…

Rescue of nonsense mutations by amlexanox in human cells

BACKGROUND: Nonsense mutations are at the origin of many cancers and inherited genetic diseases. The consequence of nonsense mutations is often the absence of mutant gene expression due to the activation of an mRNA surveillance mechanism called nonsense-mediated mRNA decay (NMD). Strategies to rescu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gonzalez-Hilarion, Sara, Beghyn, Terence, Jia, Jieshuang, Debreuck, Nadège, Berte, Gonzague, Mamchaoui, Kamel, Mouly, Vincent, Gruenert, Dieter C, Déprez, Benoit, Lejeune, Fabrice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3562214/ https://www.ncbi.nlm.nih.gov/pubmed/22938201 http://dx.doi.org/10.1186/1750-1172-7-58

Ejemplares similares

Amlexanox: Readthrough Induction and Nonsense-Mediated mRNA Decay Inhibition in a Charcot–Marie–Tooth Model of hiPSCs-Derived Neuronal Cells Harboring a Nonsense Mutation in GDAP1 Gene
por: Benslimane, Nesrine, et al.
Publicado: (2023)

Optimized approach for the identification of highly efficient correctors of nonsense mutations in human diseases
por: Benhabiles, Hana, et al.
Publicado: (2017)

Targeting nonsense-mediated mRNA decay in colorectal cancers with microsatellite instability
por: Bokhari, A’dem, et al.
Publicado: (2018)

Nonsense-mediated mRNA decay at the crossroads of many cellular pathways
por: Lejeune, Fabrice
Publicado: (2017)

Nonsense-Mediated mRNA Decay, a Finely Regulated Mechanism
por: Lejeune, Fabrice
Publicado: (2022)

Effectiveness of Amlexanox and Adcortyl for the treatment of recurrent aphthous ulcers
por: Abbasi, Farid, et al.
Publicado: (2016)

Amlexanox Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss
por: Zhang, Yong, et al.
Publicado: (2015)

Amlexanox: A Novel Therapeutic for Atopic, Metabolic, and Inflammatory Disease
por: Dosanjh, Amrita, et al.
Publicado: (2020)

Prime editing optimized RTT permits the correction of the c.8713C>T mutation in DMD gene
por: Happi Mbakam, Cedric, et al.
Publicado: (2022)

Evaluation of Pharmacological Rescue of Melanocortin-4 Receptor Nonsense Mutations by Aminoglycoside
por: Höpfner, Friederike, et al.
Publicado: (2022)

A clinical evaluation of amlexanox oral adhesive pellicles in the treatment of recurrent aphthous stomatitis and comparison with amlexanox oral tablets: a randomized, placebo controlled, blinded, multicenter clinical trial
por: Meng, Wenxia, et al.
Publicado: (2009)

The TBK1/IKKε inhibitor amlexanox improves dyslipidemia and prevents atherosclerosis
por: Zhao, Peng, et al.
Publicado: (2022)

CRISPR-Pass: Gene Rescue of Nonsense Mutations Using Adenine Base Editors
por: Lee, Choongil, et al.
Publicado: (2019)

Identification and Characterization of Amlexanox as a G Protein-Coupled Receptor Kinase 5 Inhibitor
por: Homan, Kristoff T., et al.
Publicado: (2014)

Moxifloxacin rescues SMA phenotypes in patient-derived cells and animal model
por: Januel, Camille, et al.
Publicado: (2022)

Amlexanox and UPF1 Modulate Wnt Signaling and Apoptosis in HCT-116 Colorectal Cancer Cells
por: Bordonaro, Michael, et al.
Publicado: (2019)

Amlexanox and Forskolin Prevents Isoproterenol-Induced Cardiomyopathy by Subduing Cardiomyocyte Hypertrophy and Maladaptive Inflammatory Responses
por: Adzika, Gabriel Komla, et al.
Publicado: (2021)

A role for AKT1 in nonsense-mediated mRNA decay
por: Palma, Martine, et al.
Publicado: (2021)

Aminoglycosides, but not PTC124 (Ataluren), rescue nonsense mutations in the leptin receptor and in luciferase reporter genes
por: Bolze, Florian, et al.
Publicado: (2017)

Identifying Potent Nonsense-Mediated mRNA Decay Inhibitors with a Novel Screening System
por: Carrard, Julie, et al.
Publicado: (2023)

Allele-Specific CRISPR/Cas9 Correction of a Heterozygous DNM2 Mutation Rescues Centronuclear Myopathy Cell Phenotypes
por: Rabai, Aymen, et al.
Publicado: (2019)

Amlexanox Blocks the Interaction between S100A4 and Epidermal Growth Factor and Inhibits Cell Proliferation
por: Cho, Ching Chang, et al.
Publicado: (2016)

Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses
por: Quan, Mo-Yuan, et al.
Publicado: (2019)

Assessment of Efficacy of 5% Topical Amlexanox and 0.1% Topical Triamcinolone Acetonide in Management of Recurrent Aphthous Stomatitis
por: Kavita, Kumari, et al.
Publicado: (2020)

Assessment of 5% Amlexanox, 0.1% Triamcinolone Acetonide and 0.03% Tacrolimus in the Management of Oral Lichen Planus
por: AlMutairi, Mohammed, et al.
Publicado: (2023)

Targeting the Ubiquitin-Proteasome System in Limb-Girdle Muscular Dystrophy With CAPN3 Mutations
por: Lasa-Elgarresta, Jaione, et al.
Publicado: (2022)

Stop codons and the +4 nucleotide may influence the efficiency of G418 in rescuing nonsense mutations of the HERG gene
por: Yu, Haiyun, et al.
Publicado: (2019)

2,6-Diaminopurine as a highly potent corrector of UGA nonsense mutations
por: Trzaska, Carole, et al.
Publicado: (2020)

Cyclic GMP-AMP Triggers Asthma in an IL-33-Dependent Manner That Is Blocked by Amlexanox, a TBK1 Inhibitor
por: Ozasa, Koji, et al.
Publicado: (2019)

Dual TBK1/IKKɛ inhibitor amlexanox attenuates the severity of hepatotoxin‐induced liver fibrosis and biliary fibrosis in mice
por: Zhou, Zixiong, et al.
Publicado: (2019)

Isoproterenol-Induced Cardiomyopathy Recovery Intervention: Amlexanox and Forskolin Enhances the Resolution of Catecholamine Stress-Induced Maladaptive Myocardial Remodeling
por: Adzika, Gabriel Komla, et al.
Publicado: (2021)

Cellular and Genomic Features of Muscle Differentiation from Isogenic Fibroblasts and Myoblasts
por: Benarroch, Louise, et al.
Publicado: (2023)

Skeletal muscle characteristics are preserved in hTERT/cdk4 human myogenic cell lines
por: Thorley, Matthew, et al.
Publicado: (2016)

Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System
por: Lattanzi, Annalisa, et al.
Publicado: (2017)

Prime editing strategies to mediate exon skipping in DMD gene
por: Happi Mbakam, Cedric, et al.
Publicado: (2023)

Amlexanox, a selective inhibitor of IKBKE, generates anti-tumoral effects by disrupting the Hippo pathway in human glioblastoma cell lines
por: Liu, Yang, et al.
Publicado: (2017)

Amlexanox Enhances Temozolomide-Induced Antitumor Effects in Human Glioblastoma Cells by Inhibiting IKBKE and the Akt-mTOR Signaling Pathway
por: Xiong, Jinbiao, et al.
Publicado: (2021)

Dystrophin rescue by trans-splicing: a strategy for DMD genotypes not eligible for exon skipping approaches
por: Lorain, Stéphanie, et al.
Publicado: (2013)

Small-molecule eRF3a degraders rescue CFTR nonsense mutations by promoting premature termination codon readthrough
por: Lee, Rhianna E., et al.
Publicado: (2022)

CRISPR-Cas9 correction of a nonsense mutation in LCA5 rescues lebercilin expression and localization in human retinal organoids
por: Afanasyeva, Tess A.V., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h4kkt73l60f1s2hq0eoef1iig1